ICON advises that all resolutions recommended by the Board at the Annual
General Meeting of the Company held on 20 July 2009 were duly passed.
These resolutions were set out in the Notice of the Annual General
Meeting sent to shareholders on 10 June 2009 and are available on the
ICON website www.iconplc.com.
About ICON plc
ICON plc (NASDAQ: ICLR) (ISIN: IE0005711209) is a global provider of
outsourced development services to the pharmaceutical, biotechnology and
medical device industries. The Company specialises in the strategic
development, management and analysis of programs that support clinical
development – from compound selection to Phase I-IV clinical studies.
ICON currently has over 7,000 employees, operating from 71 locations in
38 countries.
Further information is available at www.iconplc.com
ICON/ICLR-F
ICON plc
Ciaran Murray
+ 353 1 291 2000
IR@iconplc.com
